Scale of interest versus scale of estimation: Comparing alternative estimators for the incremental costs of a comorbidity

被引:46
作者
Basu, Anirban
Arondekar, Bhakti V.
Rathouz, Paul J.
机构
[1] Univ Chicago, Dept Med, Gen Internal Med Sect, Chicago, IL 60637 USA
[2] Argonne Natl Labs, Decis & Informat Sci Div, Chicago, IL USA
[3] GlaxoSmithKline Inc, Global Hlth Outcomes, Philadelphia, PA USA
[4] Univ Illinois, Chicago, IL USA
[5] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA
关键词
expenditures; log models; generalized linear models; link and variance function; myocardial infarction; heart failure;
D O I
10.1002/hec.1099
中图分类号
F [经济];
学科分类号
02 ;
摘要
We investigate how the scale of estimation in risk-adjustment models for health-care costs affects the covariate effect, where the scale of interest for the covariate effect may be different from the scale of estimation. As an illustrative example, we use claims data to estimate the incremental costs associated with heart failure within one year subsequent to myocardial infarction. Here, the scale of interest for the effect of heart failure on costs is additive. However, traditional methods for modeling costs use predetermined scale of estimation - for example, ordinary least squares (OLS) regression assumes an additive scale while log-transformed OLS and generalized linear models with log-link assume a multiplicative scale of estimation. We compare these models with a new flexible model that lets the data determine the appropriate scale of estimation. We use a variety of goodness-of-fit measures along with a modified Copas test to assess robustness, lack of fit, and over-fitting properties of the alternative estimators. Biases up to 19% in the scale of interest are observed due to the misrepresentation of the scale of estimation. The new flexible model is found to appropriately represent the scale of estimation and less susceptible to over-fitting despite estimating additional parameters in the link and the variance functions. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:1091 / 1107
页数:17
相关论文
共 43 条
[1]   THE EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ZOFENOPRIL ON MORTALITY AND MORBIDITY AFTER ANTERIOR MYOCARDIAL-INFARCTION [J].
AMBROSIONI, E ;
BORGHI, C ;
MAGNANI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02) :80-85
[2]  
[Anonymous], 1989, GEN LINEAR MODEL
[3]  
ANTMAN EM, 1997, HEART DIS TXB CARDIO, V2, P1184
[4]   Estimating marginal and incremental effects on health outcomes using flexible link and variance function models [J].
Basu, A ;
Rathouz, PJ .
BIOSTATISTICS, 2005, 6 (01) :93-109
[5]   Comparing alternative models: log vs Cox proportional hazard? [J].
Basu, A ;
Manning, WG ;
Mullahy, J .
HEALTH ECONOMICS, 2004, 13 (08) :749-765
[6]  
BIGGER JT, 1984, ANNU REV MED, V35, P127
[7]   Modeling risk using generalized linear models [J].
Blough, DK ;
Madden, CW ;
Hornbrook, MC .
JOURNAL OF HEALTH ECONOMICS, 1999, 18 (02) :153-171
[8]   AN ANALYSIS OF TRANSFORMATIONS [J].
BOX, GEP ;
COX, DR .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1964, 26 (02) :211-252
[9]  
*BUR LAB STAT, 1998, MEAS PRIC CHANG MED
[10]  
Carides G W, 2000, Biostatistics, V1, P299, DOI 10.1093/biostatistics/1.3.299